Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA026587 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA026587, RRID:AB_1846386
- Product name
- Anti-CDCA3
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human CDCA3, Gene description: cell division cycle associated 3, Alternative Gene Names: GRCC8, TOME-1, Validated applications: WB, Uniprot ID: Q99618, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.2 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references Structural investigation of CDCA3‐Cdh1 protein–protein interactions using in vitro studies and molecular dynamics simulation
Elevating CDCA3 levels in non-small cell lung cancer enhances sensitivity to platinum-based chemotherapy
Elevating CDCA3 Levels Enhances Tyrosine Kinase Inhibitor Sensitivity in TKI-Resistant EGFR Mutant Non-Small-Cell Lung Cancer
Barbhuiya T, Fisher M, Boittier E, Bolderson E, O'Byrne K, Richard D, Adams M, Gandhi N
Protein Science 2023;32(3)
Protein Science 2023;32(3)
Elevating CDCA3 levels in non-small cell lung cancer enhances sensitivity to platinum-based chemotherapy
Kildey K, Gandhi N, Sahin K, Shah E, Boittier E, Duijf P, Molloy C, Burgess J, Beard S, Bolderson E, Suraweera A, Richard D, O’Byrne K, Adams M
Communications Biology 2021;4(1)
Communications Biology 2021;4(1)
Elevating CDCA3 Levels Enhances Tyrosine Kinase Inhibitor Sensitivity in TKI-Resistant EGFR Mutant Non-Small-Cell Lung Cancer
Sahin K, Shah E, Ferguson G, Molloy C, Kalita-de Croft P, Hayes S, Hudson A, Colvin E, Kamitakahara H, Harvie R, Hasovits C, Khan T, Duijf P, Howell V, He Y, Bolderson E, Hooper J, Lakhani S, Richard D, O’Byrne K, Adams M
Cancers 2021;13(18):4651
Cancers 2021;13(18):4651
No comments: Submit comment
Enhanced validation
- Submitted by
- Atlas Antibodies (provider)
- Enhanced method
- Recombinant expression validation
- Main image
- Experimental details
- Western blot analysis in control (vector only transfected HEK293T lysate) and CDCA3 over-expression lysate (Co-expressed with a C-terminal myc-DDK tag (~3.1 kDa) in mammalian HEK293T cells, LY410572).
- Sample type
- Human
- Protocol
- Protocol
